The European Commission Approves Astellas’ XOSPATA® for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation Detected by Validated Tests, including the Invivoscribe LeukoStrat CDx FLT3 Mutation AssayInvivoscribe Marketing2021-11-14T22:08:08-08:00December 5th, 2019|2019 Press Releases, Press Releases| Read more
Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a “Spike-in” Clonal SequenceInvivoscribe Marketing2021-02-11T23:36:10-08:00November 13th, 2019|2019 Publications, Publications| Read more
AMP 2019 Video Series Part 3 of 4Invivoscribe Marketing2022-05-25T03:00:59-07:00November 6th, 2019|2019 Videos, Featured Videos, Videos| Watch video
AMP 2019 Video Series Part 4 of 4Invivoscribe Marketing2022-05-25T03:00:59-07:00November 6th, 2019|2019 Videos, Featured Videos, Videos| Watch video
AMP 2019 Video Series Part 2 of 4Invivoscribe Marketing2022-05-25T03:00:59-07:00November 6th, 2019|2019 Videos, Featured Videos, Videos| Watch video
AMP 2019 Video Series Part 1 of 4Invivoscribe Marketing2022-05-25T03:01:00-07:00November 6th, 2019|2019 Videos, Featured Videos, Videos| Watch video
Clonally-Related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implicationsInvivoscribe Marketing2021-02-11T23:40:44-08:00October 15th, 2019|2019 Publications, Publications| Read more
Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myelomaInvivoscribe Marketing2021-02-11T23:43:09-08:00October 1st, 2019|2019 Publications, Publications| Read more
NOW AVAILABLE! MRD solutions for B- and T-cell clonality trackingInvivoscribe Marketing2019-09-23T22:05:58-07:00August 26th, 2019|Product Releases| Read more
Japan’s MHLW Approves Invivoscribe’s LeukoStrat CDx FLT3 Mutation Assay as the CDx for Daiichi Sankyo’s Quizartinib for Treatment of Relapsed/Refractory FLT3-ITD AML. Expands Use to Include Specimens Collected in EDTAInvivoscribe Marketing2021-02-26T19:10:37-08:00June 19th, 2019|2019 Press Releases, Press Releases| Read more
Invivoscribe – EHA 2019: Part 3 of 3Invivoscribe Marketing2022-05-25T03:01:00-07:00June 13th, 2019|2019 Videos, Featured Videos, Videos| Watch video
Invivoscribe – EHA 2019: Part 2 of 3Invivoscribe Marketing2022-05-25T03:01:00-07:00June 13th, 2019|2019 Videos, Featured Videos, Videos| Watch video
Invivoscribe – EHA 2019: Part 1 of 3Invivoscribe Marketing2022-05-25T03:01:00-07:00June 13th, 2019|2019 Videos, Featured Videos, Videos| Watch video
Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple MyelomaInvivoscribe Marketing2021-02-15T20:01:10-08:00June 6th, 2019|2019 Publications, Publications| Read more
Invivoscribe – ASCO – LeukoStrat CDx FLT3 Mutation AssayInvivoscribe Marketing2022-05-25T03:01:00-07:00June 1st, 2019|2019 Videos, Featured Videos, Videos| Watch video
Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China. Offering Comprehensive Standardized Testing for All Hematologic MalignanciesInvivoscribe Marketing2021-02-26T19:10:45-08:00May 21st, 2019|2019 Press Releases, Press Releases| Read more
AMP Global 2019 Video Series Part 4 of 4Invivoscribe Marketing2022-05-25T03:01:01-07:00May 16th, 2019|2019 Videos, Featured Videos, Videos| Watch video
AMP Global 2019 Video Series Part 3 of 4Invivoscribe Marketing2022-05-25T03:01:01-07:00May 16th, 2019|2019 Videos, Featured Videos, Videos| Watch video
AMP Global 2019 Video Series Part 2 of 4Invivoscribe Marketing2022-05-25T03:01:01-07:00May 16th, 2019|2019 Videos, Featured Videos, Videos| Watch video
AMP Global 2019 Video Series Part 1 of 4Invivoscribe Marketing2022-05-25T03:01:01-07:00May 16th, 2019|2019 Videos, Featured Videos, Videos| Watch video
Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell NeoplasmsInvivoscribe Marketing2021-02-11T23:46:14-08:00March 21st, 2019|2019 Publications, Featured Publications, Publications| Read more
Invivoscribe To Present At Biotech Showcase™ 2019 In San Franciscowmm2021-02-26T19:10:54-08:00January 3rd, 2019|2019 Press Releases, Press Releases| Read more